Screener
Kiniksa Pharmaceuticals International, plc KNSA Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $4.92B.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's market capitalization?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported market capitalization of $4.92B in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's market capitalization changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's market capitalization increased by 132.0% year-over-year, from $2.12B to $4.92B.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's market capitalization?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's market capitalization has grown at a 20.8% compound annual growth rate (CAGR), from $1.22B to $3.13B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Kiniksa Pharmaceuticals International, plc's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude